HETEROTAXY, VISCERAL, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy, Visceral, 3, Autosomal
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 4, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 6, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Cholestasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Renal Insufficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Episodic Kinesigenic Dyskinesia 1
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
These include Invs and Anks6, which are both excellent candidates for the modifier as mutations in these genes result in PKD and both genes are known to genetically and physically interact with Nek8.
|
27114383 |
2016 |
Episodic Kinesigenic Dyskinesia 1
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Comparative phenotype analysis in cy/+ rats and our Anks6(I747N) mice further showed that the two models display noticeably different PKD phenotypes and that there is a defective interaction between ANKS6 with ANKS3 in the rat and between ANKS6 and BICC1 (bicaudal C homolog 1) in the mouse.
|
26039630 |
2015 |
Hydrocephalus, Normal Pressure
|
0.010 |
Biomarker
|
disease |
BEFREE |
We recently observed that the ankyrin repeat protein Anks3 interacts with the NPH family member Anks6.
|
26188091 |
2015 |
Congenital cystic kidney disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
These variants are unlikely to account for PKD in these patients, yet the screening of other affected populations may provide information about the involvement of PKDR1 as a modifier gene in cystic kidney disease.
|
18434273 |
2008 |
cystic disease
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Recent studies support the etiological role of the ANKS6 SAM domain in human cystic diseases, but its function in kidney remains unknown.
|
26039630 |
2015 |
Enlarged kidney
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study identifies 112 new loci for body mass index in the Japanese population.
|
28892062 |
2017 |
Renal cyst
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Evidence of renal cysts in these mice confirmed the crucial role of the SAM domain of ANKS6 in kidney function.
|
26039630 |
2015 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
RGD |
Thus, we not only provide the first in vivo evidence for a causal link between the novel Anks6((p.R823W)) gene mutation and polycystic kidney disease, but we also developed a new transgenic rat model that will serve as an important resource for further exploration of the still unknown function of Anks6.
|
21119215 |
2010 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
BEFREE |
Genomic organization and mutation screening of the human ortholog of Pkdr1 associated with polycystic kidney disease in the rat.
|
18434273 |
2008 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
BEFREE |
The ankyrin repeat and sterile α motif (SAM) domain-containing six gene (Anks6) is a candidate for polycystic kidney disease (PKD).
|
26039630 |
2015 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
RGD |
Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.
|
16207829 |
2005 |
Polycystic Kidney Diseases
|
0.320 |
Biomarker
|
group |
HPO |
|
|
|
Cystic Kidney Diseases
|
0.310 |
Biomarker
|
group |
CTD_human |
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3.
|
23793029 |
2013 |
Cystic Kidney Diseases
|
0.310 |
Biomarker
|
group |
BEFREE |
These variants are unlikely to account for PKD in these patients, yet the screening of other affected populations may provide information about the involvement of PKDR1 as a modifier gene in cystic kidney disease.
|
18434273 |
2008 |
Cardiovascular Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
We also identify six families with ANKS6 mutations affected by nephronophthisis, including severe cardiovascular abnormalities, liver fibrosis and situs inversus.
|
23793029 |
2013 |